3Janghorbani M, Rezvanian H, Kachooci A, et al. Peripheral neuropathy in type 2 diabetes mellitus inI sfab an, Iran: prevalence and risk factors[J]. Acta Neurol Scand, 2006, 114(1 ):384-391.
3[1]Thomas PK. Classification, differential diagnosis, and staging of diabetic peripheral neuropathy. Diabetes, 1997, 46 (suppl. 2):S54～S57.
4[2]Said G. Diabetic neuropathy: an update. J Neurol, 1996, 243:431～440.
5[3]Dyck PJ, Davies JL, Wilson DM, et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care,1999, 22: 1479～1486.
6[4]Bertora P, Valla P, Dezuanni E, et al. Prevalence of subclinical neuropathy in diabetic patients: assessment by study of conduction velocity distribution with motor and sensotry nerve fibres. J Neurol, 1998, 245:81～86.
7张蜀平，中华医学会第五次全国内分泌学术会议论文汇编，1997年，60页
8方圻.现代内科学[M].北京：人民军医出版社,1996.2254.
9Brownlee M.Biochemistry and molecular cell biology of diabcric comlications[J].Nature.2001,414(6865):813-820.
10Watanabe T,Yuki S,Egawa M,et al.Protective effects of MCI-186 on cerebral ischemia:possible involvement of free radical scavenging and antioxidant actions[J].J Pharmacol Exp Ther,1994,268 (3):1597-604.
